Although the biological function of TNIK in hematological cancers, such as MM and leukemia, has not been clearly investigated yet, our results suggest a new approach for treating MM stimulated by exogenous IL-6. Here, IL6 is linked to hematopoietic and lymphoid cell neoplasm.